The Value of Standardized Respiratory Rate Monitoring Exercises During Rheumatological Injection Procedures
Respi-IR
2 other identifiers
interventional
136
1 country
1
Brief Summary
The goal of this clinical trial is to demonstrate the non-inferiority of standardized breathing control exercises on perceived pain during rheumatological injections procedures compared to standard care consisting of the addition of a local anesthetic. The study population will consist of patients scheduled to undergo therapeutic ultrasound-guided joint or periarticular injection. The main question it aims to answer is:
- Non-inferiority of breathing exercises compared to the addition of local anesthetic on pain and anxiety experienced during an infiltration procedure.
- Correlation between the reduction in pain and anxiety experienced during a procedure and the cardiac coherence score obtained. Researchers will compare the anesthesia group (Arm A), which will receive local anesthesia with 5 cc of lidocaine before the infiltration procedure to the breathing group (Arm B), which will receive instructions before the injection procedure on how to perform 5-minute breathing cycles to facilitate the achievement of cardiac coherence to see if the pain perceived in Arm B is not greater than the pain perceived in Arm A. Participants will be kept blind to their randomization group. Arm A (anesthesia) will receive SHAM breathing exercises, while Arm B (breathing) will receive a placebo injection of anesthetic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2025
CompletedFirst Posted
Study publicly available on registry
September 15, 2025
CompletedStudy Start
First participant enrolled
September 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 20, 2028
January 5, 2026
December 1, 2025
3 years
September 8, 2025
December 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain during rheumatological injection
Pain perceived during rheumatological injection measured using the Visual Analog Scale between 0 to 10 (the higher score mean the worst outcome) and compared between groups.
during injection
Secondary Outcomes (3)
anxiety during procedure
during the procedure
Cardiac coherence score
during procedure
pain correlated with cardiac coherence score
end of intervention
Study Arms (2)
Anesthesia group
ACTIVE COMPARATORReceives local anesthesia with 5 cc of lidocaine before the infiltration procedure.
breathing group
EXPERIMENTALExplanations for performing 5-minute breathing cycles that facilitate the achievement of cardiac coherence, with visual feedback.
Interventions
Receives local anesthesia with 5 cc of lidocaine before the infiltration procedure.The patient will receive breathing instructions as part of "SHAM" treatment, which will not allow them to achieve cardiac coherence.
The procedure will use 5 cc of saline solution instead of the usual anesthesia. Explanations for performing 5-minute breathing cycles that facilitate the achievement of cardiac coherence, with visual feedback.
Eligibility Criteria
You may qualify if:
- Patient scheduled to undergo therapeutic ultrasound-guided joint or periarticular injection.
- Patient able to sign an informed consent form to participate in the study
You may not qualify if:
- Patient able to sign an informed consent form to participate in the study - - Allergy to the injection product or anesthetic.
- Injection not allowing the use of a local anesthetic due to insufficient joint volume (e.g., fingers/toes).
- Epidural injection via the sacrococcygeal hiatus.
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier Metropole Savoielead
- Université Savoie Mont Blanccollaborator
Study Sites (1)
Centre Hospitalier Métropole Savoie
Chambéry, 73000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2025
First Posted
September 15, 2025
Study Start
September 19, 2025
Primary Completion (Estimated)
September 20, 2028
Study Completion (Estimated)
September 20, 2028
Last Updated
January 5, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share